Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Gustafsson (Skovde, Sweden). Lung Clearance Index (LCI). Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis

Member's Comments

No comment yet.

Related content which might interest you: Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD). Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease Year: 2019 Use of Lung Clearance Index (LCI) to distinguish asthmatics within a symptomatic population. Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Lung Clearance Index (LCI) derived from N2-Multiple Breath Washout (MBW) depicts worsening in airways colonization in pediatric Cystic Fibrosis (CF) patients (pts) Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 Assessment of Global Lung Function Initiative (GLI) reference equations for diffusing capacity in relation to respiratory burden in the Swedish CArdioPulmonary bioImage Study (SCAPIS) Source: Eur Respir J, 56 (2) 1901995; 10.1183/13993003.01995-2019 Year: 2020 Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 Global Lung Function Initiative: Reference Equations for TLCO  Source: International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring Year: 2017 Small Airways Disease and Emphysema (Assessed by High-Resolution CT) and Symptom Burden in COPD Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Outcomes of a Multi-Disciplinary Team (MDT) for End-Stage Emphysema Patients: Emphysema Index on Computed Tomography identifies Targets for Lung Volume Reduction  Source: International Congress 2017 – Thoracic surgery: preoperative assessment, outcome and complications Year: 2017 Agreement Between COPD Assessment Test (CAT) And Modified Medical Research Council (mMRC) Dyspnea Scores For GOLD COPD Classification: A Cross-Sectional Analyses Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 LATE-BREAKING ABSTRACT: Daytime motor activity and emphysema on CT: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung and Sleep Studies Source: International Congress 2014 – Mechanisms of exercise limitation in disease Year: 2014 Impact of Emphysema Heterogeneity on Lung Function after Bronchoscopic Lung Volume Reduction Source: International Congress 2019 – Interventional pulmonology: re-sculpting the airway Year: 2019 Correlation between Lung Clearance Index (LCI) with SF6 and single breath diffusing capacity testing in elderly patients Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Implementation of a Paediatric Bronchiectasis Severity Index (PBSI) Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 Outcome of Nasal High Flow Nasal Oxygen Therapy (HFNO) in Acute Hypoxemic Respiratory Failure (AHRF) on an Acute Respiratory Care Unit (ARCU) Source: Sleep and Breathing Conference 2021 Year: 2021 Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Comparison of Respiratory Muscle Strength, Functional Capacity and Peak Oxygen Uptake In Patients With End-Stage Liver Disease and Liver Transplantation Source: Virtual Congress 2020 – A knowledge update on respiratory muscle function, assessment and training Year: 2020 Quantitative Functional Respiratory Imaging may predict the mechanism of FEV1 Decline after Lung Transplantation Source: International Congress 2017 – Lung transplant outcomes Year: 2017 Severity classification of DSP in ILD Source: International Congress 2014 – Respiratory function at rest and during exercise Year: 2014